HK1119771A1 - Devices and methods for diagnosing or predicting early stage cardiac dysfunctions - Google Patents
Devices and methods for diagnosing or predicting early stage cardiac dysfunctionsInfo
- Publication number
- HK1119771A1 HK1119771A1 HK08111542.2A HK08111542A HK1119771A1 HK 1119771 A1 HK1119771 A1 HK 1119771A1 HK 08111542 A HK08111542 A HK 08111542A HK 1119771 A1 HK1119771 A1 HK 1119771A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- devices
- methods
- diagnosing
- early stage
- cardiac dysfunctions
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Electrotherapy Devices (AREA)
- External Artificial Organs (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05010043A EP1722232A1 (fr) | 2005-05-09 | 2005-05-09 | Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques |
PCT/EP2006/062031 WO2006120152A1 (fr) | 2005-05-09 | 2006-05-03 | Dispositifs et methodes permettant de diagnostiquer ou de predire des dysfonctionnements cardiaques a un stade precoce |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1119771A1 true HK1119771A1 (en) | 2009-03-13 |
Family
ID=34936290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08111542.2A HK1119771A1 (en) | 2005-05-09 | 2008-10-17 | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110104813A1 (fr) |
EP (2) | EP1722232A1 (fr) |
JP (1) | JP4927825B2 (fr) |
CN (2) | CN103091497A (fr) |
AT (1) | ATE482398T1 (fr) |
CA (1) | CA2605247A1 (fr) |
DE (1) | DE602006017058D1 (fr) |
ES (1) | ES2352351T3 (fr) |
HK (1) | HK1119771A1 (fr) |
WO (1) | WO2006120152A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1722232A1 (fr) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques |
HUE025408T2 (hu) | 2007-01-25 | 2016-02-29 | Hoffmann La Roche | IGFBP-7 alkalmazása szívelégtelenség megítélésében |
EP2425016B1 (fr) | 2009-04-29 | 2015-04-01 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Moyens et procédés pour contrebalancer, prévenir et/ou déterminer une insuffisance cardiaque, ou un risque d'insuffisance cardiaque |
EP2646822B1 (fr) * | 2010-11-29 | 2017-11-01 | Alere San Diego, Inc. | Procédés pour le diagnostic et la prédiction du risque d'insuffisance cardiaque |
JP6298054B2 (ja) | 2012-08-09 | 2018-03-20 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 心不全の診断 |
CN106716135B (zh) * | 2014-10-10 | 2019-03-15 | 松森昭 | 用于检测心力衰竭的装置及储存介质 |
WO2017210488A1 (fr) * | 2016-06-03 | 2017-12-07 | Cedars-Sinai Medical Center | Dosage protéolytique du peptide natriurétique de type b pour l'évaluation du risque de maladie cardiovasculaire |
US11193947B2 (en) | 2016-06-03 | 2021-12-07 | Cedars-Sinai Medical Center | B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment |
EP3499230A4 (fr) * | 2016-08-09 | 2020-07-29 | Otsuka Pharmaceutical Co., Ltd. | Procédé d'aide au diagnostic de la maladie d'alzheimer mettant en uvre un biomarqueur de l'urine |
EP3665483A4 (fr) * | 2017-08-08 | 2021-07-14 | Queensland University of Technology | Méthodes pour diagnostiquer les stades précoces de l'insuffisance cardiaque |
US11255844B2 (en) * | 2018-03-06 | 2022-02-22 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related methods |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
JP2676114B2 (ja) * | 1990-04-16 | 1997-11-12 | 塩野義製薬株式会社 | hBNPを認識するモノクローナル抗体および該抗体を用いるhBNPの免疫測定法 |
DK1698901T3 (da) * | 1999-01-29 | 2008-12-08 | Roche Diagnostics Gmbh | Metode til at detektere N-terminalt proBNP |
US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
AUPS169202A0 (en) * | 2002-04-11 | 2002-05-16 | Goetze, Jens Peter | Neuropeptide assay |
MXPA03004105A (es) * | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
GB0216191D0 (en) * | 2002-07-11 | 2002-08-21 | Univ Leicester | Plasma urotensin in human heart failure |
US8263325B2 (en) * | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
US7109023B2 (en) * | 2002-11-18 | 2006-09-19 | Princeton Biomeditech Corporation | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients |
US20040265926A1 (en) * | 2002-11-21 | 2004-12-30 | Leong Ng | Bodily fluid markers of tissue hypoxia |
US7092759B2 (en) * | 2003-07-30 | 2006-08-15 | Medtronic, Inc. | Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion |
US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
EP1722232A1 (fr) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques |
-
2005
- 2005-05-09 EP EP05010043A patent/EP1722232A1/fr not_active Withdrawn
-
2006
- 2006-05-03 ES ES06754992T patent/ES2352351T3/es active Active
- 2006-05-03 CA CA002605247A patent/CA2605247A1/fr not_active Abandoned
- 2006-05-03 CN CN2013100056784A patent/CN103091497A/zh active Pending
- 2006-05-03 JP JP2008510547A patent/JP4927825B2/ja active Active
- 2006-05-03 EP EP06754992A patent/EP1880221B1/fr active Active
- 2006-05-03 DE DE602006017058T patent/DE602006017058D1/de active Active
- 2006-05-03 CN CN2006800158682A patent/CN101171517B/zh active Active
- 2006-05-03 AT AT06754992T patent/ATE482398T1/de active
- 2006-05-03 WO PCT/EP2006/062031 patent/WO2006120152A1/fr not_active Application Discontinuation
-
2007
- 2007-11-07 US US11/936,169 patent/US20110104813A1/en not_active Abandoned
-
2008
- 2008-10-17 HK HK08111542.2A patent/HK1119771A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1880221A1 (fr) | 2008-01-23 |
WO2006120152A1 (fr) | 2006-11-16 |
ES2352351T3 (es) | 2011-02-17 |
CN103091497A (zh) | 2013-05-08 |
DE602006017058D1 (de) | 2010-11-04 |
CA2605247A1 (fr) | 2006-11-16 |
US20110104813A1 (en) | 2011-05-05 |
EP1722232A1 (fr) | 2006-11-15 |
EP1880221B1 (fr) | 2010-09-22 |
JP4927825B2 (ja) | 2012-05-09 |
JP2008541078A (ja) | 2008-11-20 |
CN101171517B (zh) | 2013-10-09 |
ATE482398T1 (de) | 2010-10-15 |
CN101171517A (zh) | 2008-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1119771A1 (en) | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions | |
EP2315034A3 (fr) | Moyens et procédés d'évaluation du risque d'interventions cardiaques basées sur GDF-15 | |
ATE545032T1 (de) | Diagnose von herz-kreislauf-erkrankung | |
WO2007062090A3 (fr) | Procedes et compositions lies a des analyses de lymphocytes b | |
WO2005071407A3 (fr) | Methodes | |
WO2010025393A3 (fr) | Marqueurs biologiques protéiques et méthodes pour diagnostiquer la maladie de kawasaki | |
WO2005118878A3 (fr) | Methodes de criblage de proliferation cellulaire ou de troubles neoplasiques | |
EP2177908A3 (fr) | Marqueurs associés au diabète et procédés d'utilisation de ceux-ci | |
EP1745287A4 (fr) | Diagnostic et suivi de maladies inflammatoires par la mesure de composants du complement sur des leucocytes | |
WO2008061149A3 (fr) | Procédés et compositions de diagnostic et de pronostic de la sténose d'artère rénale | |
EP1819827A4 (fr) | Methodes de diagnostic et de traitement de la maladie de crohn | |
BRPI0410261A (pt) | método de detecção de probnp natural | |
WO2007056523A3 (fr) | Procedes de diagnostic et de surveillance de la progression d'un cancer | |
WO2009101059A3 (fr) | Procédés d'utilisation d'antagonistes de la cadhérine 11 (cdh11) | |
DK1756571T3 (da) | Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande | |
WO2005121362A3 (fr) | Methode de quantification selective d'isoformes de vegf dans un echantillon biologique et ses utilisations | |
WO2008042826A3 (fr) | Utilisation d'omentine1 et d'omentine pour le diagnostic et le traitement de maladies | |
WO2006002930A3 (fr) | Polymorphisme fcgammariia et son utilisation dans un diagnostic | |
ATE473448T1 (de) | Verfahren zur diagnose von herz-kreislauf- krankheiten | |
WO2008131261A3 (fr) | Biomarqueurs peptidiques de maladie cardiovasculaire | |
WO2008080030A3 (fr) | Panel de maladies auto-immunes cardiovasculaires et méthodes d'utilisation correspondantes | |
WO2005034737A3 (fr) | Diagnostic et traitement de troubles du reticulum endoplasmique | |
ATE437182T1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
ATE509270T1 (de) | Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung | |
WO2003068958A1 (fr) | Procede d'analyse d'un acide nucleique specifiant un gene presentant une modification de son niveau d'expression liee a la schizophrenie |